| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
753 |
722 |
$98K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
79 |
74 |
$31K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
55 |
52 |
$23K |
| 80053 |
Comprehensive metabolic panel |
199 |
187 |
$9K |
| 87486 |
|
79 |
74 |
$3K |
| 87581 |
|
79 |
74 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
237 |
113 |
$3K |
| 87070 |
|
13 |
12 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
79 |
76 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
332 |
293 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
79 |
74 |
$802.23 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
33 |
32 |
$770.37 |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$432.80 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
33 |
32 |
$181.82 |
| 81001 |
|
12 |
12 |
$5.32 |
| 36415 |
Collection of venous blood by venipuncture |
214 |
183 |
$0.00 |